CN108837090A - A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system - Google Patents
A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system Download PDFInfo
- Publication number
- CN108837090A CN108837090A CN201811020489.3A CN201811020489A CN108837090A CN 108837090 A CN108837090 A CN 108837090A CN 201811020489 A CN201811020489 A CN 201811020489A CN 108837090 A CN108837090 A CN 108837090A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- respiratory system
- intensive care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 33
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 31
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 25
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 23
- 239000010440 gypsum Substances 0.000 claims abstract description 23
- 241000758794 Asarum Species 0.000 claims abstract description 22
- 244000241872 Lycium chinense Species 0.000 claims abstract description 22
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 22
- 235000004347 Perilla Nutrition 0.000 claims abstract description 22
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 22
- 235000012907 honey Nutrition 0.000 claims abstract description 21
- 241000792500 Calvatia fenzlii Species 0.000 claims abstract description 20
- 239000010231 banlangen Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 7
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- -1 oral solution Substances 0.000 claims description 3
- 229940100688 oral solution Drugs 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 20
- 206010011224 Cough Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 5
- 210000003800 pharynx Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000008017 Hypohidrosis Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QOSTVEDABRQTSU-UHFFFAOYSA-N 1,4-bis(methylamino)anthracene-9,10-dione Chemical group O=C1C2=CC=CC=C2C(=O)C2=C1C(NC)=CC=C2NC QOSTVEDABRQTSU-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system, which is made of the raw material components of following parts by weight：15-28 parts of asarum, Radix Ophiopogonis 13-21 part, 8-19 parts of reed root, 7-15 parts of gypsum, 15-23 parts of perilla leaf, 11-20 parts of Lasiosphaera fenzlii, 9-20 parts of indigo naturalis, 12-22 parts of Radix Isatidis, 11-21 parts of the root bark of Chinese wolf-berry, 7-11 parts of Radix Glycyrrhizae, 5-9 parts of honey.The present invention utilizes drug matching principle, and a variety of medicinal materials are used cooperatively, and has developed a kind of Chinese medicine preparation that can treat Intensive Care Therapy infection in respiratory system, drug effective percentage is up to 98.7%, and quick, pharmacological property mitigates, and toxic side effect is small, no dependence is conducive to patient and mitigates symptom in time.
Description
Technical field
The invention belongs to pharmaceutical technology field, be related to a kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system and
Preparation method.
Background technique
Respiratory system is the general name for executing body and the extraneous organ for carrying out gas exchanges.The function of respiratory system is mainly
Gas exchanges are carried out with the external world, are given off carbon dioxide, inspiration oxygen carries out metabolism.Respiratory system includes respiratory tract (nose
Chamber, pharynx, larynx, trachea-bronchial epithelial cell) and lung.
Respiratory disease is a kind of common disease, frequently-occurring disease, and major lesions are in trachea-bronchial epithelial cell, lung and thoracic cavity, lesion
Less serious case's mostly cough, pectoralgia, breathing is impacted, severe one has difficulty in breathing, anoxic or even respiratory failure and it is lethal.Death in city
Rate accounts for the 3rd, and in rural area then account for the first.Infection in respiratory system is maximum, most common class in respiratory disease, past
Toward with fever, inflammation, the pain of cough and respiratory system.
Doctor trained in Western medicine mostly uses antibiotic, antiviral and hormonotherapy at present, and therapeutic effect is barely satisfactory, and side effect is big,
Easily cause the abuse of antibiotic.Chinese medicine thinks, the scopes such as " cough " of infection in respiratory system category traditional Chinese medicine, " phlegm retention ", " cough and asthma ".
Think exopathogen invasion and lung, spleen, the dirty malfunction of kidney three, is the main reason for causing this disease.Human righteousness is insufficient, defends outer mistake
Duty, being invaded by exogenous pathogen,invasion of exogenous pathogen, exopathogen either chill heresy, can also be the heresy of wind-heat, can also chill heresyization heat, invade lungs, make
It is respectful that lung loses a surname；Or insufficiency of lung-QI, weakened defensive QI feel exopathogen again；Or weak with age, spleen-lung Qi deficiency, the dysfunction of the spleen in transport, it is wet to be polymerized to
Phlegm stops storing in lung；Or lung has chronic ill, feels exopathogen again；Or after prolonged illness, kidney is undermined by spleen and lung, leads to deficiency of kidney-QI, gas of receiving is had no right
Deng.Mainly there is following parting：1, chill beam table.Card is shown in：Aversion to wind and cold is heavier, and with fever, lossless or hypohidrosis is had a stuffy nose, stream
Clear nasal discharge is sneezed, headache, limb aching pain, and not thirsty or cough spits dilute white phlegm, hoarseness, thin white fur of tongue and moisten, floating and tense pulse.It controls
Then：Relieving the exterior syndrome with drugs pungent in flavor and warm in property, fever chill.2, wind-heat violates table.Card is shown in：Fever is obvious, micro- aversion to wind and cold, hypohidrosis, distending pain in the head, nasal obstruction, or stream
Yellow tears, it is thirsty, red and pain is swallowed, yellow phlegm or white viscous phlegm are spat in cough, and tongue side point is red, and tongue fur is thin white and dry or micro- Huang, superficial and rapid pulse.The rules for the treatment of：
Relieving the exterior syndrome with drugs pungent in flavor and cool in property, evacuation fever.3, summer-heat and damp attacks table.Card is shown in：Disease hair rises in summer symptoms include fever with aversion to cold, lossless or hypohidrosis, giddy
Bitterly, nasal congestion, uncomfortable in chest, evil of vomitting is intended to spit, and tire is white greasy or yellow greasy, soft and moderate pulse or moistens number.The rules for the treatment of：Driving away summer heat inducing diaphoresis, dampness elimination is in.4,
Heat attacks table.Card is shown in：Disease is mainly in autumn, symptoms include fever, slight chill, headache, hypohidrosis, and few phlegm of coughing, thirsty, dry throat lip is dry, skin
Skin is dry, and tongue side point is red, and tongue fur is thin white and dry, floating pulse.The rules for the treatment of：Relieving the exterior syndrome with drugs pungent in flavor and cool in property, sweet tremble with fear are moisturized.
The present invention selects plurality of Chinese to carry out compatibility, this fundamentally treats Intensive Care Therapy infectious disease of respiratory system, reaches
Treating both manifestation and root cause of disease.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system,
Preparation gained Chinese medicine has that good curative effect, quick, medication time is short, treatment is complete for treatment Intensive Care Therapy infection in respiratory system
Face, toxic side effect are small, drug goes directly lesion, treating both manifestation and root cause of disease.
The technical scheme adopted by the invention is that a kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system, by
The raw material components of following parts by weight are made：15-28 parts of asarum, Radix Ophiopogonis 13-21 part, 8-19 parts of reed root, 7-15 parts of gypsum, perilla leaf
15-23 parts, 11-20 parts of Lasiosphaera fenzlii, 9-20 parts of indigo naturalis, 12-22 parts of Radix Isatidis, 11-21 parts of the root bark of Chinese wolf-berry, 7-11 parts of Radix Glycyrrhizae, honey 5-9
Part.
Further, a kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system, by the raw material of following parts by weight
Component is made：20-25 parts of asarum, Radix Ophiopogonis 15-19 part, 12-16 parts of reed root, 12-15 parts of gypsum, 18-21 parts of perilla leaf, Lasiosphaera fenzlii
15-20 parts, 13-17 parts of indigo naturalis, 14-19 parts of Radix Isatidis, 17-20 parts of the root bark of Chinese wolf-berry, 8-11 parts of Radix Glycyrrhizae, 5-7 parts of honey.
Further, a kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system, by the raw material of following parts by weight
Component is made：22 parts of asarum, 17 parts of Radix Ophiopogonis, 15 parts of reed root, 14 parts of gypsum, 20 parts of perilla leaf, 18 parts of Lasiosphaera fenzlii, 15 parts of indigo naturalis, plate
17 parts of blue root, 19 parts of the root bark of Chinese wolf-berry, 10 parts of Radix Glycyrrhizae, 6 parts of honey.
A kind of preparation method of the Chinese medicine composition for Intensive Care Therapy infection in respiratory system, prepares as follows：
(1) 15-28 parts of asarum, Radix Ophiopogonis 13-21 part, 8-19 parts of reed root, 7-15 parts of gypsum, purple are weighed respectively in parts by weight
15-23 parts of perilla leaf, 11-20 parts of Lasiosphaera fenzlii, 9-20 parts of indigo naturalis, 12-22 parts of Radix Isatidis, 11-21 parts of the root bark of Chinese wolf-berry, 7-11 parts of Radix Glycyrrhizae, bee
It is 5-9 parts sweet；
(2) add water slightly boiled asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, Lasiosphaera fenzlii, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae
It decocts three times, for the first time plus is equivalent to 10-13 times of above-mentioned raw materials gross mass and measures water, decoct 75-90min, second plus be equivalent to
8-10 times of above-mentioned raw materials gross mass measures water, decocts 45-60min, third time plus is equivalent to 6-8 times of above-mentioned raw materials gross mass and measures water,
25-45min is decocted, collecting decoction cools filtering, is concentrated under reduced pressure, and vacuum drying obtains dry extract, spare；
(3) the resulting Chinese medicine dry extract of step (2) is added into honey, auxiliary material, the finished dosage forms of clinical needs is made.
Tablet, pill, granule, oral can be made in a kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system
Liquid, powder, tincture, capsule or syrup.
The effect of forming each bulk pharmaceutical chemicals of the invention activity is as follows：
The present invention is using asarum, Radix Ophiopogonis as monarch drug in a prescription.Asarum：Warm-natured acrid flavour；Return heart, lung, kidney channel；Expelling wind and clearing away cold, wind-expelling pain-stopping,
It is sensible, warming lung and resolving fluid；For anemofrigid cold, have a headache, toothache, nasal congestion, allergic rhinitis, nasosinusitis, rheumatic arthralgia, sputum cough.Wheat
Winter：This product is the dried root of liliaceous plant Radix Ophiopogonis (dwarf lilyturf)；It is sweet in flavor, slight bitter, cold nature；Return heart, lung, stomach meridian；Yin-nourishing
It promotes the production of body fluid, moistening lung and clearing away the heart-fire.
Reed root, gypsum, perilla leaf are ministerial drug of the invention.Reed root：It is cold in nature sweet in flavor；Distributed in lung channel, stomach meridian；Clearing heat and promoting fluid is removed
It is tired, preventing or arresting vomiting, diuresis；For pyreticosis and polydipsia, gastropyretic vomiting, cough with lung heat, lung carbuncle pyemesis, puckery pain of heat gonorrhea.Gypsum：This product is sulfuric acid
Saline minerals anhydrite race gypsum, the main (CaSO containing hydrous calcium sulfate4·2H2O), after excavation, silt and miscellaneous stone are removed；Sweet in flavor,
It is pungent, property Great Cold；It attaches to the lung and stomach meridians；Clearing heat-fire, relieving restlessness are quenched the thirst.Perilla leaf：Warm-natured acrid flavour；Return lung, the spleen channel；Relieving exterior syndrome and dispelling cold, promoting the circulation of qi
Stomach function regulating, for anemofrigid cold, cough vomiting.
Lasiosphaera fenzlii, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry are adjutant of the invention.Lasiosphaera fenzlii：Acrid flavour is mild-natured；It is clearing heat and detoxicating, promoting the dispersing function of the lung is sharp
Pharynx, function arrogate to oneself surname dissipate.Indigo naturalis：Bitter is cold in nature；Clearing heat and detoxicating, cooling blood and hemostasis, is longer than heat-clearing.Lasiosphaera fenzlii and indigo naturalis Papillary, are played altogether
The effect of clearing heat and detoxicating, reducing pharyngeal swelling analgesic, for treating abscess of throat because of person caused by heat evil fire toxin.Radix Isatidis：Cold in nature, taste is first
It is bitter after slightly sweet；There is the effect of clearing heat and detoxicating, preventing cold, relieving sore-throat；It is dark reddish purple dark, rotten to be mainly used for treatment febrile virulent maculae, tongue
The diseases such as larynx scarlet fever.Removing toxic substances relieving sore-throat.The root bark of Chinese wolf-berry：It is sweet natured；It is distributed in lung channel；Cool blood is used for chronic cough and dyspnea of deficiency type except precious, clearing lung-heat fall fire.
Radix Glycyrrhizae, honey make medicine for of the invention.Radix Glycyrrhizae：It is sweet in flavor, it is mild-natured；It invigorates the spleen and benefits qi, is clearing heat and detoxicating, expelling phlegm and arresting coughing, delaying
Anxious analgesic, coordinating the drug actions of a prescription；For weakness of the spleen and the stomach, fatigue and weakness, shortness of breath and palpitation, coughing with a lot of sputum, wrist abdomen, four limbs contraction, swelling
Swollen sore alleviates drug toxicity, is strong.Honey：《Compendium of Materia Medica》Carry " function being used as medicine has five, heat-clearing also, bowl spares also, removing toxic substances also,
Moisturize also, analgesic.It is raw then cool in nature, therefore can heat-clearing；It is ripe then warm-natured, therefore can bowl spares；It is sweet and gentle, therefore can detoxify；Soft and Ru Ze,
Therefore it can moisturize；It is slow to go urgency, therefore trusted subordinate's muscle sore pain can be stopped；With it can cause in, therefore hundred medicines can be reconciled, and with the same function of Radix Glycyrrhizae ".
The beneficial effects of the invention are as follows：The present invention utilizes drug matching principle, and a variety of medicinal materials are used cooperatively, are had developed
A kind of Chinese medicine preparation that can treat Intensive Care Therapy infection in respiratory system, drug effective percentage are up to 98.7%, and quick, pharmacological property is delayed
With toxic side effect is small, no dependence, is conducive to patient and mitigates symptom in time.The all medicine compatibility of the present invention is made a general survey of, is played altogether and inducing diaphoresis
In, soothing the liver rising Yang, clearing heat-fire, nourishing Yin and promoting production of body fluid, eliminating dampness dissolving phlegm, sweating expelling pathogenic factors from muscles and skin, clearing heat and cooling blood, removing blood stasis and acesodyne, tonifying middle-Jiao and Qi, dispel
Phlegm and relieving cough, diuresis of promoting the production of body fluid, the effect of reinforcing the spleen to benefit the lung are suitable for treatment Intensive Care Therapy infectious disease of respiratory system.
Specific embodiment
In order to enable those skilled in the art to more fully understand, technical solution of the present invention is practiced, below with reference to specific
The invention will be further described for embodiment, but illustrated embodiment is not as a limitation of the invention.
Embodiment 1
A kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system of the present embodiment, by the raw material group of following parts by weight
Divide and is made：22 parts of asarum, 17 parts of Radix Ophiopogonis, 15 parts of reed root, 14 parts of gypsum, 20 parts of perilla leaf, 18 parts of Lasiosphaera fenzlii, 15 parts of indigo naturalis, plate are blue
17 parts of root, 19 parts of the root bark of Chinese wolf-berry, 10 parts of Radix Glycyrrhizae, 6 parts of honey.
Preparation method：(1) it is grouped as by above-mentioned raw materials group and weighs asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, horse respectively
Suddenly, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae, honey；
(2) add water slightly boiled asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, Lasiosphaera fenzlii, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae
It decocts three times, for the first time plus is equivalent to 12 times of amount water of above-mentioned raw materials gross mass, decocts 80min, for the second time plus be equivalent to above-mentioned original
Expect 9 times of amount water of gross mass, decoct 50min, third time, which adds, is equivalent to 7 times of amount water of above-mentioned raw materials gross mass, decocts 40min, merges
Decocting liquid cools filtering, is concentrated under reduced pressure, and vacuum drying obtains dry extract, spare；
(3) the resulting Chinese medicine dry extract of step (2) is added into honey, auxiliary material, utilizes modern general Chinese materia medica preparation skill
Oral solution is made in art.
Embodiment 2
A kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system of the present embodiment, by the raw material group of following parts by weight
Divide and is made：20 parts of asarum, 15 parts of Radix Ophiopogonis, 12 parts of reed root, 12 parts of gypsum, 18 parts of perilla leaf, 15 parts of Lasiosphaera fenzlii, 13 parts of indigo naturalis, plate are blue
14 parts of root, 17 parts of the root bark of Chinese wolf-berry, 8 parts of Radix Glycyrrhizae, 5 parts of honey.
Preparation method：(1) it is grouped as by above-mentioned raw materials group and weighs asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, horse respectively
Suddenly, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae, honey；
(2) add water slightly boiled asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, Lasiosphaera fenzlii, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae
It decocts three times, for the first time plus is equivalent to 10 times of amount water of above-mentioned raw materials gross mass, decocts 75min, for the second time plus be equivalent to above-mentioned original
Expect 8 times of amount water of gross mass, decoct 45min, third time, which adds, is equivalent to 6 times of amount water of above-mentioned raw materials gross mass, decocts 30min, merges
Decocting liquid cools filtering, is concentrated under reduced pressure, and vacuum drying obtains dry extract, spare；
(3) the resulting Chinese medicine dry extract of step (2) is added into honey, auxiliary material, utilizes modern general Chinese materia medica preparation skill
Syrup is made in art.
Embodiment 3
A kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system of the present embodiment, by the raw material group of following parts by weight
Divide and is made：25 parts of asarum, 19 parts of Radix Ophiopogonis, 16 parts of reed root, 15 parts of gypsum, 21 parts of perilla leaf, 20 parts of Lasiosphaera fenzlii, 17 parts of indigo naturalis, plate are blue
19 parts of root, 20 parts of the root bark of Chinese wolf-berry, 11 parts of Radix Glycyrrhizae, 7 parts of honey.
Preparation method：(1) it is grouped as by above-mentioned raw materials group and weighs asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, horse respectively
Suddenly, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae, honey；
(2) add water slightly boiled asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, Lasiosphaera fenzlii, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae
It decocts three times, for the first time plus is equivalent to 13 times of amount water of above-mentioned raw materials gross mass, decocts 90min, for the second time plus be equivalent to above-mentioned original
Expect 10 times of amount water of gross mass, decoct 60min, third time, which adds, is equivalent to 8 times of amount water of above-mentioned raw materials gross mass, decocts 45min, merges
Decocting liquid cools filtering, is concentrated under reduced pressure, and vacuum drying obtains dry extract, spare；
(3) the resulting Chinese medicine dry extract of step (2) is added into honey, auxiliary material, utilizes modern general Chinese materia medica preparation skill
Pill is made in art.
Embodiment 1-3 is the significant Chinese medicine composition of therapeutic effect, wherein 1 gained Intensive Care Therapy of embodiment breathing system
The clinical application of togetherness dye disease treatment Chinese medicine：In 300 patients of 3 hospital's screening ages between 18-70 years old, wherein
Women 150, male 150, wherein 100 patients are due to pulmonary infection；100 patients are due to tracheae or bronchus sense
Dye；100 patients are throat, tonsillotome, nasal cavity infection.
The crowd is observed continuously in the last week of experiment, records symptom and variation, is randomly divided into two groups, experimental group
And control group, experimental group use the made Chinese medicine of the embodiment of the present invention 1, control group uses commonly treatment respiratory system sense in the market
The drug of dye.
Curative effect situation criterion：It is effective：Complications shape disappears substantially after medication seven days；Effectively：Disease hair after medication seven days
Symptom is reduced；In vain：There is no any variation after taking seven days or once improves, the rear symptom restored to before treating again.
Instructions of taking：The oral solution that the embodiment of the present invention 1 is prepared is taken during treating, a 15mL is sooner or later each daily
It takes once, continuously takes seven days, the results are shown in Table 1.
Table 1 takes the verifying of 1 products obtained therefrom therapeutic effect of embodiment
| Experimental group | Control group | |
| Number of cases | 150 | 150 |
| Male's number of cases | 75 | 75 |
| Women number of cases | 75 | 75 |
| Pulmonary infection | 50 | 50 |
| Tracheae or bronchial infection | 50 | 50 |
| Throat, tonsillotome, nasal cavity infection | 50 | 50 |
| Effective number of cases | 132 | 89 |
| Effective number of cases | 16 | 49 |
| Invalid number of cases | 2 | 12 |
| It is efficient | 98.7% | 92% |
Therapeutic effect：From table 1, it is apparent that taking treatment Intensive Care Therapy respiratory system obtained by the embodiment of the present invention 1
Effective and effective totally 148 (98.7%) of the experimental group of infection tcm product is invalid 2 (1%).And control group is effective
Rate only reaches 92%, and the experimental group for taking treatment Intensive Care Therapy infection in respiratory system tcm product obtained by the present invention is substantially better than
Take the control group of other drugs.
Disclosed above is only specific embodiments of the present invention, and still, the embodiment of the present invention is not limited to this, Ren Heben
What the technical staff in field can think variation should all fall into protection scope of the present invention.
Claims (5)
1. a kind of Chinese medicine composition for Intensive Care Therapy infection in respiratory system, which is characterized in that by the raw material of following parts by weight
Component is made：
15-28 parts of asarum, Radix Ophiopogonis 13-21 part, 8-19 parts of reed root, 7-15 parts of gypsum, 15-23 parts of perilla leaf, 11-20 parts of Lasiosphaera fenzlii,
9-20 parts of indigo naturalis, 12-22 parts of Radix Isatidis, 11-21 parts of the root bark of Chinese wolf-berry, 7-11 parts of Radix Glycyrrhizae, 5-9 parts of honey.
2. being used for the Chinese medicine composition of Intensive Care Therapy infection in respiratory system as described in claim 1, which is characterized in that by following
The raw material components of parts by weight are made：
20-25 parts of asarum, Radix Ophiopogonis 15-19 part, 12-16 parts of reed root, 12-15 parts of gypsum, 18-21 parts of perilla leaf, Lasiosphaera fenzlii 15-20
Part, 13-17 parts of indigo naturalis, 14-19 parts of Radix Isatidis, 17-20 parts of the root bark of Chinese wolf-berry, 8-11 parts of Radix Glycyrrhizae, 5-7 parts of honey.
3. being used for the Chinese medicine composition of Intensive Care Therapy infection in respiratory system as claimed in claim 2, which is characterized in that by following
The raw material components of parts by weight are made：
22 parts of asarum, 17 parts of Radix Ophiopogonis, 15 parts of reed root, 14 parts of gypsum, 20 parts of perilla leaf, 18 parts of Lasiosphaera fenzlii, 15 parts of indigo naturalis, Radix Isatidis 17
Part, 19 parts of the root bark of Chinese wolf-berry, 10 parts of Radix Glycyrrhizae, 6 parts of honey.
4. the preparation method of the Chinese medicine composition a method according to any one of claims 1-3 for Intensive Care Therapy infection in respiratory system,
It is characterized in that, preparing as follows：
(1) 15-28 parts of asarum, Radix Ophiopogonis 13-21 part, 8-19 parts of reed root, 7-15 parts of gypsum, perilla leaf are weighed respectively in parts by weight
15-23 parts, 11-20 parts of Lasiosphaera fenzlii, 9-20 parts of indigo naturalis, 12-22 parts of Radix Isatidis, 11-21 parts of the root bark of Chinese wolf-berry, 7-11 parts of Radix Glycyrrhizae, honey 5-9
Part；
(2) asarum, Radix Ophiopogonis, reed root, gypsum, perilla leaf, Lasiosphaera fenzlii, indigo naturalis, Radix Isatidis, the root bark of Chinese wolf-berry, Radix Glycyrrhizae are added into the slightly boiled decoction of water
Three times, it for the first time plus is equivalent to 10-13 times of above-mentioned raw materials gross mass and measures water, decoct 75-90min, second plus be equivalent to above-mentioned
8-10 times of total mass of raw material is measured water, decocts 45-60min, third time plus is equivalent to 6-8 times of above-mentioned raw materials gross mass and is measured water, is decocted
25-45min, collecting decoction cool filtering, are concentrated under reduced pressure, and vacuum drying obtains dry extract, spare；
(3) Chinese medicine dry extract obtained in step (2) is added into honey, auxiliary material, the finished dosage forms of clinical needs is made.
5. being used for the Chinese medicine composition of Intensive Care Therapy infection in respiratory system as claimed in claim 4, which is characterized in that in described
Tablet, pill, granule, oral solution, powder, tincture, capsule or syrup can be made in drug composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811020489.3A CN108837090A (en) | 2018-09-03 | 2018-09-03 | A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811020489.3A CN108837090A (en) | 2018-09-03 | 2018-09-03 | A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108837090A true CN108837090A (en) | 2018-11-20 |
Family
ID=64189513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811020489.3A Pending CN108837090A (en) | 2018-09-03 | 2018-09-03 | A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108837090A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2431852A1 (en) * | 2000-12-14 | 2002-06-20 | Globoasia Llc. | Herbal pharmaceutical compositions for treating immunological disorders |
| CN102475846A (en) * | 2010-11-27 | 2012-05-30 | 冯文明 | Pneumonia preventing and treating tablet |
| CN105572262A (en) * | 2016-02-10 | 2016-05-11 | 李兴惠 | Method for detecting traditional Chinese medicine composition heat clearing and dredging granules |
| CN106620234A (en) * | 2017-03-11 | 2017-05-10 | 王艳萍 | Cough-relieving traditional Chinese medicine composition and preparation method and application thereof |
-
2018
- 2018-09-03 CN CN201811020489.3A patent/CN108837090A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2431852A1 (en) * | 2000-12-14 | 2002-06-20 | Globoasia Llc. | Herbal pharmaceutical compositions for treating immunological disorders |
| CN102475846A (en) * | 2010-11-27 | 2012-05-30 | 冯文明 | Pneumonia preventing and treating tablet |
| CN105572262A (en) * | 2016-02-10 | 2016-05-11 | 李兴惠 | Method for detecting traditional Chinese medicine composition heat clearing and dredging granules |
| CN106620234A (en) * | 2017-03-11 | 2017-05-10 | 王艳萍 | Cough-relieving traditional Chinese medicine composition and preparation method and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| 王新陆: "《王新陆医论医案集》", 31 March 2016, 中国医药科技出版社 * |
| 胡志坚: "《中药临证应用》", 31 August 1981, 内蒙古人民出版社 * |
| 苗明三、孙玉信、王晓田: "《中药大辞典》", 30 June 2017, 山西科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352587A (en) | Ointment for treating rhinitis | |
| CN104069474B (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof | |
| CN102755593A (en) | Traditional Chinese medicine composition for treating qi goiter and preparation method thereof | |
| CN106620097A (en) | Cough-relieving plaster prepared from traditional Chinese medicine composition, and preparation method of cough-relieving plaster | |
| CN101129755A (en) | Orally taken traditional Chinese medicine composition for treating asthma | |
| CN1931262B (en) | Common cold treating Chinese medicine preparation | |
| CN108837090A (en) | A kind of Chinese medicine composition and preparation method for Intensive Care Therapy infection in respiratory system | |
| CN105343274A (en) | Drug combination having inflammation diminishing and cough relieving functions | |
| CN110721303A (en) | Traditional Chinese medicine composition for treating allergic rhinitis and application thereof | |
| CN101317946B (en) | Medicament for treating chronic bronchitis, pneumonectasis and preparation method thereof | |
| CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
| CN104173737A (en) | Traditional Chinese medicine formula for treating pulmonary interstitial fibrosis | |
| CN104147334A (en) | Traditional Chinese medicine formula capable of eliminating phlegm | |
| CN115531503B (en) | External traditional Chinese medicine composition for novel coronavirus pneumonia recovery period, acupoint patch, preparation method and application | |
| CN115300544B (en) | Traditional Chinese medicine composition and patch for dispelling wind, relieving exterior syndrome, detumescence and inducing resuscitation and preparation method thereof | |
| CN103920056B (en) | Aerosol inhalation liquid for preventing postoperative tracheospasm and preparation method thereof | |
| CN108126008A (en) | Rosemary cordyceps sinensis ball | |
| CN101327281A (en) | Traditional Chinese medicine for treating facial paralysis caused by apoplexy | |
| CN105381351A (en) | Traditional Chinese medicine for treating infantile asthma caused by lung qi obstruction | |
| CN105106814A (en) | Traditional Chinese medicine combination for treating viral rhinitis | |
| CN104826072A (en) | Traditional Chinese medicine preparation for treating respiratory system infection and preparation method of traditional Chinese medicine preparation | |
| CN108159219A (en) | A kind of Chinese medicine for treating asthma in children | |
| CN103948682A (en) | Traditional Chinese medicine for treating arrhythmia caused by insufficiency of heart blood | |
| CN108042676A (en) | Chinese medicine preparation for allergic rhinitis and preparation method thereof | |
| CN107496626A (en) | It is a kind of to be used to treat pill medicine of nasal obstruction and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181120 |
|
| RJ01 | Rejection of invention patent application after publication |